Figure 4. Analysis of AS in treatment of AA. (A, B) Peripheral blood cell and BMNCs counts in the different groups. (C, D) Hematopoietic tissue assay and bone marrow biopsy of different mice groups on day 14 (×400). (E) Treg and Th17 cells were detected using FCM. (F) The Treg/Th17 ratio in different AA groups. (G) The levels of IL-17A and TGF-β in different groups. Note: *P < 0.05 and **P < 0.01 compared with the normal control group. ▲P < 0.05 and ▲▲P < 0.01 compared with the model control group, #P < 0.05 and ##P < 0.01 compared with the low-dose group.